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Transvaginal probes have enhanced sonographic depiction of the uterus and ovaries over
that obtained with conventional transabdominal scans. Cyclic variations of female pelvic
hemodynamics and angiogenesis can be studied with Doppler ultrasound. The power
Doppler has a threefold increase in sensitivity compared with conventional color Doppler
imaging at detecting low velocity flow. There have been numerous investigations on the
applications of the assessment of uterine and perifollicular vascularity and their possible
relation with the treatment of infertility. However, the main applications in infertility so far are
follicular monitoring and endometrium measurement by traditional two-dimensional (2-D)
ultrasound. Nowadays, sonography plays a vital role in tracking follicular development
and endometrial assessment in patients receiving ovulation-induction medication. The
sonographic information can be coupled with estradiol values to provide an accurate assess-
ment of the presence or absence and number of mature follicles. The maximal follicle size is
the main point to consider giving human chorionic gonadotropin and ovum pick-up.
Three-dimensional (3-D) ultrasound is a new imaging modality which is being introduced
into clinical practice. It has been proved that 3-D ultrasound is a very highly reproducible
technique. With 3-D ultrasound, a volume of a region of interest can be acquired and
stored. This volume can be further analyzed in several ways, such as navigation, multiplanar
display and surface rendering or volume calculation. Power Doppler ultrasound, in combina-
tion with 3-D ultrasound, allows for a whole assessment of relevant vessels and quantitative
assessment of vessel density and perfusion within a specified area. A whole evaluation is
then possible for endometrial and subendometrial vascularization and also for ovarian stro-
mal vascularity. Further, structure anomaly, such as septate uterus, can be understood more
clearly with 3-D ultrasound. However, data in the literature on 3-D ultrasound assessment
of endometrial receptivity to predict in vitro fertilization (IVF) outcome are controversial.
Ovarian volume and antral follicle numbers have been shown to be an indicator of ovarian
reserve and reproductive potential. A recent comparative meta-analysis has demonstrated
that the predictive performance of ovarian volume toward poor response is clearly infe-
rior compared with that of antral follicle count (AFC). AFC may be considered the test of
first choice when estimating quantitative ovarian reserve before IVF. In combination with
3-D ultrasound, the use of power Doppler in examining ovarian stromal blood supply still
fails to prove its role in predicting ovarian response and pregnancy in the IVF treatment
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and in the intrauterine insemination treatment. Although 3-D ultrasound has probably not
replaced 2-D ultrasound, it is being increasingly used in the clinical setting. 3-D ultrasound
has become an indispensable and auxiliary tool, alongside with 2-D ultrasound.
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Introduction
The development and clinical application of trans-
vaginal probes have greatly enhanced sonographic
depiction of the uterus and ovaries over that obtained
with conventional transabdominal scans. The major
factors that have contributed to this enhancement
include a shorter probe-to-target distance, which
allows use of higher-frequency transducers, and the
use of multi-element phased linear arrays, which
afford more tightly focused beams with higher line
densities than conventional real-time probes. Ultra-
sound has actually become one of the indispen-
sable diagnostic tools in the field of obstetrics and
gynecology. This review will focus on the clinical
application in infertility only.
Application of Traditional Transvaginal
Sonography
Endometrium measurement [1,2]
Transvaginal sonography allows for a more complete
evaluation of the endometrium than conventional
transabdominal techniques. It delineates specifically
the endometrium with anterior-posterior (AP) length
on long-axial scan and width on semi-axial scan. The
sonographer must be careful to image the endome-
trium in the long- and semi-axial planes in which the
two layers of the endometrium appear symmetric.
After menarche, the endometrium undergoes
cyclic changes in its thickness and texture that can
be related to the relative amount of serum estrogen
and progesterone. During the menstrual phase, the
endometrium appears as an echogenic interrupted
interface of 1–4 mm in AP width. A hypoechoic
outer layer can be identified surrounding the endo-
metrium, corresponding to the inner layer of myo-
metrium. This hypoechoic appearance of the inner
myometrium may be related to the more compact
configuration of the myometrial cells in this area or
the relatively smaller content of connective tissue and
smooth muscle of the intermediate and external lay-
ers of the myometrium. One to 2mm vessels can be
seen in the external myometrium representing a ven-
ous plexus in the outer portion of the myometrium.
During the proliferative phase, the endometrium
thickens between 4 and 8mm and has an isoechoic
or slightly hyperechoic texture relative to the outer
myometrium. In the late proliferative or periovu-
latory phase of endometrial development, a multi-
layered endometrium can be depicted. The inner
hypoechoic area probably represents edema in the
compact layer of the endometrium. As imaged in a
semi-axial or semi-coronal plane, the endometrium
has the configuration of a theta with respect to the
hypoechoic areas. This finding has been described as
an indication that ovulation is near. However, with
transvaginal sonography, this finding is noted both
prior to and immediately following ovulation [2].
In the secretory phase, the endometrium achieves 
a width of between 8 and 16 mm and is echogenic,
most likely related to the increased mucus and glyco-
gen within the glands as well as the increased num-
ber of interfaces created by tortuous glands in this
phase. The endometrium typically achieves its great-
est thickness in the midsecretory phase of a spon-
taneous cycle, measuring up to 14 mm in width.
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The data in the Table serves as a guideline for
normal values of endometrial thickness in women
with cyclic menstruation [1].
Follicular monitoring [1,2]
When menarche begins, approximately 200,000
follicles remain per ovary. During the childbearing
years, approximately 200 oocytes will be ovulated.
This indicates that approximately 99.9% of primary
oocytes become atretic or do not develop at all [2].
Maturation of the oocyte and follicle is responsive
primarily to changes in follicle-stimulating hormone
(FSH), luteinizing hormone (LH) and circulating
levels of estradiol (E2). With the elaboration and
release of FSH in the late secretory phase, there is 
a recruitment of a group of preantral follicles and
development in a subsequent cycle. When the
dominant follicle is selected, LH reinitiates meiosis of
the oocyte and ovulation typically occurs within
36 hours of its “surge” in circulating levels. E2 is
synthesized by the granulosa cells and provides
important feedback to the pituitary in the produc-
tion of FSH and LH.
Sonography can track the developing follicles,
beginning at the time they measure between 3 and
5 mm. In the spontaneous cycle, there are usually
one or at the most two follicles that develop to app-
roximately 10 mm in size. As the follicle matures,
more and more fluid is elaborated into its center
and the number of granulosa cells lining the inside
wall of the follicle increases. The oocyte itself, which
is less than 0.1 mm, is surrounded by a cluster of
granulosa cells. This complex is termed the cumu-
lus oophorus. It measures approximately 1 mm and
can be depicted occasionally inside mature follicles.
As the follicle reaches maturity, its inner dimensions
range from 17 to 25 mm. Intrafollicular echoes may
be observed with mature follicles, probably rising
from clusters of granulosa cells that shear the wall
close to the time of ovulation. After ovulation, the fol-
licular wall becomes irregular as the follicle becomes
“deflated”. The corpus luteum usually appears as
an echogenic structure with a small hypoechoic cen-
ter. As the corpus luteum develops some 4–8 days
after ovulation, it appears as an echogenic struc-
ture approximately 15 mm in size. In addition, the
undesirable development of multiple immature fol-
licles, rather than development of a single domi-
nant follicle, can be recognized in patients with
polycystic ovaries. Sonographic finding has been
included as one of the three criteria for polycystic
ovary syndrome [3,4]. Presence of 12 or more fol-
licles in each ovary measuring 2–9 mm in diameter
and/or increased ovarian volume (>10 mL) fulfill
the sonographic findings.
Nowadays, sonography plays a vital role in track-
ing follicular development in patients receiving
ovulation-induction medications. Since the matu-
rity of the oocyte can only be indirectly inferred by
the size of the follicle, the sonographic information
can be coupled with E2 values to provide an ac-
curate assessment of the presence or absence and
number of mature follicles. The maximal follicle
size is the main point to consider giving human
chorionic gonadotropin and ovum pick-up.
In addition to delineation of changes in follicle
size and morphology, sonography can depict the
presence of intraperitoneal fluid. It is not uncommon
to have approximately 1–3 mL in the cul-de-sac
prior to ovulation. When ovulation occurs, there is
typically between 4 and 5 mL within the cul-de-sac.
When the patient is scanned with a fully distended
bladder, the fluid may be located outside of the
cul-de-sac, surrounding bowel loops in the lower
abdomen and upper pelvis [2].
Measuring the volume of both ovaries or count-
ing the number of small antral follicles by ultrasound
has been suggested to predict well the ovarian
reserve and outcomes of assisted reproductive tech-
nologies (ART) [5,6]. Till now, antral follicle count
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(AFC) is still considered the test of first choice to
estimate quantitative ovarian reserve before in vitro
fertilization (IVF) [7].
Assessment of Neovascularization with
Color Doppler and Power Doppler
It has been suggested that neovascularization may
be of prime importance in the growth and selection
of ovulatory follicles. Several studies have examined
the cyclic variations of female pelvic hemodynamics
and angiogenesis using Doppler ultrasound [8,9].
Since then, transvaginal pulse Doppler has been
used quite extensively to assess uterine and ovarian
blood flow patterns in ART cycles [10–12]. Later,
there have been increasing publications suggest-
ing that the use of color flow imaging may assist in
the management of ART cycles [13–15]. However,
power Doppler or color angio-ultrasonography has
aroused attention since its introduction. The power
Doppler has a threefold increase in sensitivity com-
pared with conventional color Doppler imaging at
detecting low velocity flow [16,17]. There have been
reports about applications in relation to the assess-
ment of uterine [18] and perifollicular vascularity
[19,20] and outcome of IVF. Similar applications were
reported of perifollicular vascularity [21] and uterine
perfusion and outcome of intrauterine insemination
(IUI) [22,23].
The Era of Three-dimensional (3-D)
Ultrasound
The advent of 3-D ultrasound has widened the field
of clinical application. With this technology, any de-
sired plane through an organ can be obtained. With
3-D ultrasound, a volume of a region of interest can
be acquired and stored. This volume can be further
analyzed in several ways, such as navigation, multi-
planar display and surface rendering or volume cal-
culation. Power Doppler ultrasound, in combination
with 3-D ultrasound, allows for a whole assessment of
relevant vessels and quantitative assessment of vessel
density and perfusion within a specified area (Fig.).
Fig. Example of three-dimensional (3-D) ultrasound for endometrial measurement in multiplanar image by the power Doppler
mode. Transverse, longitudinal and frontal view in upper right, upper left and lower left plane, respectively. The rendering 3-D
projection of the vascular images is shown in the lower right plane.
A whole evaluation is then possible for endometrial
and subendometrial vascularization [24–26] and also
for ovarian stromal vascularity [27–29].
With 3-D ultrasound, researchers focus on
improvement of clinical application over two-
dimensional (2-D) ultrasound. Endometrial volume
measurement is a new tool, at least as good as
endometrial thickness measurement in predicting
pituitary suppression during IVF [30]. Endometrial
and subendometrial blood flow measurement has
been thought as indicators for uterine receptivity
and outcome of treatment [31,32]. However, litera-
ture about 3-D ultrasound assessment of endome-
trial receptivity was reviewed by Alcazar [26]. He has
found that data from studies analyzing the role of
3-D ultrasound for predicting IVF outcome are con-
troversial. His explanation for these controversial
findings was that it might be the different design
of reported studies, especially the timing of ultra-
sound evaluation. Interestingly, endometrial vol-
ume in spontaneous cycles grows during follicular
phase and remains constant through the luteal
phase [33,34]. Endometrial vascularization increases
during follicular phase, peaking 2–3 days before
ovulation, decreasing thereafter and increasing
again during mid and late luteal phase [35,36].
A variety of hormonal markers have been used
to predict ovarian reserve in infertile women, such
as cycle day 3 FSH, E2 and inhibin B, as well as
challenge tests [37–40]. Ovarian volume and antral
follicle numbers have been shown to be indicators
of reproductive potential [5,6,41,42]. Ovarian vol-
ume has been claimed as a better predictor of ovar-
ian reserve than several other predictors, including
the AFC [43]. A meta-analysis showed that AFC
performed better in the prediction of outcome in
IVF than basal FSH [44]. Moreover, a recent com-
parative meta-analysis has demonstrated that the
predictive performance of ovarian volume toward
poor response is clearly inferior compared with that
of AFC. AFC may be considered the test of first
choice when estimating quantitative ovarian reserve
before IVF. For the prediction of cases with a very
low chance for pregnancy, ovarian reserve testing
with the use of ultrasound appears inadequate [7].
As to the role of ovarian stromal vascularity detected
by 3-D power Doppler flow indices, recent studies
do not support it as a good predictor of ovarian
response and pregnancy in the IVF treatment [29].
It has been postulated that increased ovarian
stromal vascularity may lead to a greater delivery
of gonadotropins to the granulosa cells of the
developing follicles. Ovarian stromal vascularity can
be assessed by color or power Doppler ultrasound.
Power Doppler is better applied to the study of
ovarian stromal vascularity, as it is more sensitive to
lower velocities and essentially angle-independent
[45]. Ovarian stromal vascularity has been meas-
ured by 2-D power Doppler ultrasound and there
was no predictive value for the ovarian response
[46]. In combination with 3-D ultrasound, the use
of power Doppler in examining ovarian stromal
blood supply still fails to prove its role in predicting
ovarian response and pregnancy in IVF treatment
[29] and IUI treatment [47].
Structure Anomaly
By using transvaginal ultrasound, it is possible to per-
form a precise assessment of the uterine morphol-
ogy, including the endometrial lining and the outer
shape of the uterine muscle. With instillation of iso-
tonic saline solution into uterine cavity through a
catheter, the intrauterine pathologies, such as sub-
mucous myomas, endometrial polyps and septate
uteri, can be accurately diagnosed. The patency 
of bilateral tubes can be detected too. The proce-
dure is called sonohysterography, which is particu-
larly useful in infertile patients [48–50]. The color
Doppler technique allows simultaneous visualiza-
tion of the morphology and the vascular network,
giving full information on the type of anomaly and
the extent of the defect. The visualization of the
myometrial portion is further enhanced by detection
of myometrial vessels by the color Doppler tech-
nique. Furthermore, Doppler imaging can detect
deficient intraseptal vascularity and/or inadequate
endometrial development in patients with a septate
uterus [51].
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3-D ultrasound enables precise evaluation of the
fundal indentation and the length of the septum 
in the case of septate uteri. However, the techni-
que may give an incorrect impression of an arcu-
ate uterus in patients with fundal location of a
leiomyoma. Furthermore, shadowing caused by
the uterine fibroids, irregular endometrial lining and
decreased volume of the uterine cavity (in cases of
intrauterine adhesions) are limitations of 3-D ultra-
sound. 3-D power Doppler has been used to detect
the vascularization of uterine septa in a combined
angiographic and gray-rendering mode. This appro-
ach allows simultaneous analysis of the morphology,
texture and vascularization [51].
Conclusion
3-D ultrasound is a new imaging modality which 
is being introduced into clinical practice. It has
been proved that 3-D ultrasound is a very highly
reproducible technique. For the clinical stage of
infertility, however, the main actor still remains as
the traditional 2-D ultrasound. It seems that the
chief applications in infertility, so far, are follicular
monitoring and endometrium measurement. Al-
though 3-D ultrasound has probably not replaced
2-D ultrasound, it is being increasingly used in the
clinical setting. 3-D ultrasound has become an in-
dispensable and auxiliary tool, alongside with 2-D
ultrasound.
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